Eyenovia Shares Drop 14% Amid Betaliq Merger Talks
Combining Eyenovia's Optejet dispensing system with Betaliq's EyeSol medication delivery mechanism, the purchase would create ...
Eyenovia falls on plans to seek reverse merger
Eyenovia (EYEN) stock falls as the company plans a reverse merger with Betaliq, to create an ophthalmology focused drugmaker. Read more here.
Ophthalmology Times15h
Formosa Pharmaceuticals enters into licensing agreement with Cipla for commercialization of APP13007 across 11 countries
Formosa Pharmaceuticals and Cipla Limited have entered into an exclusive licensing agreement for the commercialization of ...
Eyenovia enters non-binding LOI to effect reverse merger with Betaliq
Eyenovia (EYEN), has entered into a non-binding letter of intent contemplating a potential reverse merger transaction with Betaliq, a clinical ...
Eyenovia Plans All-Stock Reverse Merger With Betaliq
Eyenovia on Thursday said it has signed a non-binding letter of intent to combine with clinical-stage pharmaceutical company Betaliq in an all-stock reverse merger. Eyenovia said Betaliq investors ...
The Manila Times18h
Intermap's Insurance Business Starts 2025 With Strong Growth
As a reminder, Intermap will report its fourth quarter and full year 2024 results on Thursday, March 27, 2025 at 5:00 pm ET. The Company's CEO Patrick Blott, CFO Jennifer Bakken and COO Jack Schneider ...
Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq
Combination, if successful, would create a new publicly-listed eye care company combining Betaliq’s EyeSol® water-free drug delivery technology for glaucoma with Eyenovia’s Optejet® device platform ...
Eyenovia, Inc.: Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq
Combination, if successful, would create a new publicly-listed eye care company combining Betaliq's EyeSol® water-free drug delivery technology for glaucoma with Eyenovia's Optejet® device platform Th ...